Ankeet S Bhatt1, Andrew P Ambrosy2,3, Eric J Velazquez4,5. 1. Department of Medicine, Duke University Medical Center, Durham, NC, USA. 2. Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA. andrew.ambrosy@dm.duke.edu. 3. Duke Clinical Research Institute, Durham, NC, USA. andrew.ambrosy@dm.duke.edu. 4. Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA. 5. Duke Clinical Research Institute, Durham, NC, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review it to summarize the current literature on remodeling after myocardial infarction, inclusive of pathophysiological considerations, imaging modalities, treatment strategies, and future directions. RECENT FINDINGS: As patients continue to live longer after myocardial infarction (MI), the prevalence of post-MI heart failure continues to rise. Changes in the left ventricle (LV) after MI involve complex interactions between cellular and extracellular components, under neurohormonal regulation. Treatments to prevent adverse LV remodeling and promote reverse remodeling in the post-MI setting include early revascularization, pharmacotherapy aimed at neurohormonal blockade, and device-based therapies that address ventricular dyssynchrony. Despite varying definitions of adverse LV remodeling examined across multiple imaging modalities, the presence of an enlarged LV cavity and/or reduced ejection fraction is consistently associated with poor clinical outcomes. Advances in our knowledge of the neurohormonal regulation of adverse cardiac remodeling have been instrumental in generating therapies aimed at arresting adverse remodeling and promoting reserve remodeling. Further investigation into other specific mechanisms of adverse LV remodeling and pathways to disrupt these mechanisms is ongoing and may provide incremental benefit to current evidence-based therapies.
PURPOSE OF REVIEW: The purpose of this review it to summarize the current literature on remodeling after myocardial infarction, inclusive of pathophysiological considerations, imaging modalities, treatment strategies, and future directions. RECENT FINDINGS: As patients continue to live longer after myocardial infarction (MI), the prevalence of post-MI heart failure continues to rise. Changes in the left ventricle (LV) after MI involve complex interactions between cellular and extracellular components, under neurohormonal regulation. Treatments to prevent adverse LV remodeling and promote reverse remodeling in the post-MI setting include early revascularization, pharmacotherapy aimed at neurohormonal blockade, and device-based therapies that address ventricular dyssynchrony. Despite varying definitions of adverse LV remodeling examined across multiple imaging modalities, the presence of an enlarged LV cavity and/or reduced ejection fraction is consistently associated with poor clinical outcomes. Advances in our knowledge of the neurohormonal regulation of adverse cardiac remodeling have been instrumental in generating therapies aimed at arresting adverse remodeling and promoting reserve remodeling. Further investigation into other specific mechanisms of adverse LV remodeling and pathways to disrupt these mechanisms is ongoing and may provide incremental benefit to current evidence-based therapies.
Entities:
Keywords:
Heart failure; Ischemic cardiomyopathy; Left ventricle; Myocardial infarction; Remodeling
Authors: Thomas G von Lueder; Bing H Wang; Andrew R Kompa; Li Huang; Randy Webb; Pierre Jordaan; Dan Atar; Henry Krum Journal: Circ Heart Fail Date: 2014-10-31 Impact factor: 8.790
Authors: Rainer Hoffmann; Stephan von Bardeleben; Jaroslaw D Kasprzak; Adrian C Borges; Folkert ten Cate; Christian Firschke; Stephane Lafitte; Nidal Al-Saadi; Stefanie Kuntz-Hehner; Georg Horstick; Christian Greis; Marc Engelhardt; Jean Louis Vanoverschelde; Harald Becher Journal: J Am Coll Cardiol Date: 2005-12-15 Impact factor: 24.094
Authors: M St John Sutton; M A Pfeffer; T Plappert; J L Rouleau; L A Moyé; G R Dagenais; G A Lamas; M Klein; B Sussex; S Goldman Journal: Circulation Date: 1994-01 Impact factor: 29.690
Authors: Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf Journal: N Engl J Med Date: 2003-11-10 Impact factor: 91.245
Authors: Nick S R Lan; Bu B Yeap; P Gerry Fegan; Gillian Green; James M Rankin; Girish Dwivedi Journal: Int J Cardiovasc Imaging Date: 2020-09-21 Impact factor: 2.357
Authors: Belén Alvarez-Alvarez; Javier García-Seara; Jose L Martínez-Sande; Moisés Rodríguez-Mañero; Xesús A Fernández López; Laila González-Melchor; Diego Iglesias-Alvarez; Francisco Gude; Carla Díaz-Louzao; José R González-Juanatey Journal: J Arrhythm Date: 2021-03-21